Treatment for Covid-Related Loss of Smell: Insider Wales Sport

Treatment for Covid-Related Loss of Smell: Insider Wales Sport

Title: Promising Treatment for Loss of Smell in Long Covid Patients Discovered by Researchers

Date: [Insert date]

Researchers have potentially discovered an effective treatment for the loss of smell, also known as anosmia, caused by long Covid. The treatment involves a minimally invasive procedure called a stellate ganglion block, which is commonly used to treat pain and circulation issues. These findings offer hope to long Covid patients who have been struggling with this debilitating symptom.

In a study conducted on 54 patients with post-Covid parosmia, researchers administered the stellate ganglion block injection. This procedure involves injecting local anesthetic around the stellate ganglion, a group of nerves located in the neck region. The aim is to block the abnormal nerve signals responsible for loss of smell.

The results of the study were promising, with 59% of patients reporting an improved sense of smell just one week after the injection. Furthermore, the progress continued to be reported even a month later. Remarkably, most patients who showed improvement after the first injection experienced continued improvement after a second injection as well.

During the three-month trial period, responders reported an average improvement of 49% in their symptoms. Some patients even experienced a complete recovery of their sense of smell, marking a significant breakthrough in the treatment of this condition.

While these findings are encouraging, it is important to note that the study was conducted on a small sample size and has yet to go through the rigorous process of peer review. As such, caution should be exercised in interpreting the results until further research can confirm their validity.

See also  Anticipating the Future: What to Expect in the Year Ahead for Weight Loss Drug Boom

However, considering the lack of available treatment options for long Covid symptoms, the potential of stellate ganglion block as a treatment for Covid-related loss of smell is worth further investigation. This breakthrough offers hope to the millions of long Covid patients who have been suffering from this persistent symptom and opens up possibilities for new avenues of treatment.

As research in this area continues to develop, insights such as these will provide valuable information for medical professionals and long Covid patients seeking relief. It is anticipated that further studies will be conducted on a larger scale to validate and expand upon these initial findings.

For the latest updates on this promising treatment and other developments in the long Covid landscape, stay tuned to Insider Wales Sport.

You May Also Like

About the Author: Piers Parker

Alcohol maven. Incurable pop culture specialist. Communicator. Gamer. Certified explorer.

Leave a Reply

Your email address will not be published. Required fields are marked *